Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Coeptis Therapeutics Holdings, Inc. (COEP) had Operating Cash Flow per Share of $-0.77 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$0.06M |
|
$-3.06M |
|
$0.05M |
|
$0.02M |
|
$4.12M |
|
$-4.06M |
|
$0.64M |
|
$-3.42M |
|
$-3.42M |
|
$-3.42M |
|
$-3.42M |
|
$-3.42M |
|
$-3.42M |
|
$-4.06M |
|
$-3.66M |
|
3.07M |
|
3.07M |
|
$-1.11 |
|
$-1.11 |
|
| Balance Sheet Financials | |
$4.65M |
|
$0.01M |
|
$8.80M |
|
$13.45M |
|
$5.65M |
|
$0.15M |
|
$0.34M |
|
$5.99M |
|
$7.46M |
|
$6.97M |
|
$7.46M |
|
3.37M |
|
| Cash Flow Statement Financials | |
$-2.37M |
|
-- |
|
$6.10M |
|
$0.53M |
|
$4.27M |
|
$3.74M |
|
$1.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.82 |
|
-- |
|
-- |
|
0.02 |
|
0.27 |
|
28.18% |
|
-6452.56% |
|
-6452.56% |
|
-- |
|
-5440.95% |
|
-4863.27% |
|
$-2.37M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-45.84% |
|
-49.11% |
|
-25.43% |
|
-44.94% |
|
$2.22 |
|
$-0.77 |
|
|
Operating Cash Flow per Share |
$-0.77 |